Konstantin Poukalov
CIK 1678736 · Executive Vice President, CFO · last filed 2024-06-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
13
Lifetime Open-Market Net
$23.24M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYRA | Director | — | $0.70 | — | $0 | 5 | 2024-06-14 |
| LianBio (LIAN) Delisted | Director | 36,300 | $0.32 | $11.6K | $0 | 3 | 2024-02-20 |
| Landos Biopharma, Inc. (LABP) Delisted | Director | 14,869,915 | $22.93 | $340.97M | $23.21M | 2 | 2021-02-09 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Executive Vice President, CFO | 3,000 | $9.50 | $28.5K | $23.2K | 3 | 2017-12-12 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-12 | Kadmon Holdings, Inc. (KDMN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-16 | Kadmon Holdings, Inc. (KDMN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-14 | Kadmon Holdings, Inc. (KDMN) Delisted | Buy (P) | +4,000 | $23.2K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.